Universal Health Services, Inc. filings document the financial results, governance practices and capital structure of a healthcare-services company operating acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points through subsidiaries. Form 8-K reports include operating and financial results, material agreements, credit-facility disclosures and other corporate events.
UHS proxy materials cover shareholder voting matters, board oversight, executive compensation and incentive-plan arrangements. The company’s regulatory disclosures also address risk factors, legal proceedings, ownership and governance matters, and capital actions such as share repurchases, dividends and financing arrangements.
Universal Health Services, Inc. reported solid growth for the three months ended March 31, 2026. Net revenues rose 9.6% to $4.495 billion, while net income attributable to UHS increased to $348.7 million, or $5.65 per diluted share, up from $4.80 a year earlier. Adjusted net income was $346.5 million, or $5.62 per diluted share.
EBITDA net of noncontrolling interests was $651.7 million and Adjusted EBITDA net of NCI was $648.3 million. Same-facility acute care net revenues grew 8.2%, driven mainly by higher revenue per admission and patient day, while same-facility behavioral health revenues rose 7.3% on modest volume and pricing gains.
Operating cash flow improved to $401.6 million. The company amended its credit agreement in April 2026 to add an aggregate $900 million of borrowing capacity, including a new $400 million delayed draw term loan A tied to the planned acquisition of Talkspace, Inc., and continued capital returns with 675,000 Class B shares repurchased for about $127.3 million.
Universal Health Services, Inc. amended its long-standing senior secured credit agreement through an Eleventh Amendment, adding new revolving and term loan capacity and updating pricing. The company now has a new $200 million incremental revolving facility, a $300 million incremental tranche A term loan and a $400 million delayed draw term loan under its Senior Secured Credit Facility. The delayed draw term loan is intended to fund the previously announced acquisition of Talkspace, Inc. All incremental loans generally mature on September 26, 2029 and carry margins tied to the company’s Consolidated Net Leverage Ratio. The company also executed supplemental indentures adding new subsidiary guarantors to its various senior secured notes.
Universal Health Services, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on director elections, executive pay, auditor ratification, and two governance-related stockholder proposals. Holders of different share classes elect specific directors and vote together on other items, including a nonbinding say-on-pay resolution and the reappointment of PricewaterhouseCoopers LLP for 2026.
The meeting will be held online on May 20, 2026, for stockholders of record as of March 23, 2026. The Board recommends voting for its director nominees, for executive compensation and auditor ratification, and against the two stockholder proposals on vote reporting and workforce diversity disclosure. The proxy also highlights 2025 results, including consolidated net revenues of $17.36 billion, up 9.7% from 2024, and adjusted diluted EPS of $21.74, a 30.9% increase.
Sim Edward H reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services Executive Vice President Edward H. Sim received an equity award of 6,404 shares of Class B Common Stock. The filing describes these as restricted stock units granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan, vesting in equal portions on March 26 of 2027, 2028, 2029 and 2030. Following this grant, Sim directly holds 24,790 shares, reflecting routine, compensation-related equity rather than an open-market purchase.
Peterson Matthew Jay reported acquisition or exercise transactions in this Form 4 filing.
UNIVERSAL HEALTH SERVICES INC Executive Vice President Matthew Jay Peterson received a grant of 5,627 restricted stock units of Class B Common Stock at no cost as equity compensation. The units were granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan and will vest in four equal annual installments on March 26 of 2027, 2028, 2029 and 2030. After this award, Peterson directly holds a total of 31,984.2263 shares of Class B Common Stock, including 591.2263 shares previously purchased at a discounted rate through the 2005 Employee Stock Purchase Plan.
MILLER ALAN B reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services Executive Chairman Alan B. Miller received an equity award of 14,153 Class B share units as a grant under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan. The units will vest in equal portions on March 26 of 2027, 2028, 2029 and 2030.
After this award, Miller directly holds 1,796,166 shares of Class B Common Stock. The filing also lists additional Class B shares held through various family trusts, grantor retained annuity trusts and a foundation associated with Miller, for which he disclaims beneficial ownership.
No open-market purchases or sales of Universal Health Services stock are reported in this filing; the activity reflects compensation-related equity and updated indirect holdings.
Miller Marc D reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services President and CEO Marc D. Miller received a grant of 29,715 shares of Class B Common Stock, effectively at no cost, as an equity award. According to the plan terms, these restricted stock units vest in equal parts on 3/26/2027, 3/26/2028, 3/26/2029 and 3/26/2030. Following this grant, Miller directly owns 388,621 Class B shares and also has indirect ownership through several family trusts, including 49,294 shares held by The Abby Danielle Miller 2002 Trust and 69,726 shares held by The Marni Spencer 2002 Trust.
FILTON STEVE reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services Executive Vice President & CFO Steve Filton received a grant of 6,850 restricted stock units tied to Class B Common Stock. The award was made at no cash cost as part of his equity compensation.
The restricted stock units were granted under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan and will vest in four equal annual installments on 3/26/2027, 3/26/2028, 3/26/2029 and 3/26/2030. Following this grant, Filton directly holds 144,715 shares of Class B Common Stock. The filing also notes indirect holdings of 80,500 shares in The Betsy H. Filton 2020 Irrevocable Trust and 80,500 shares in The Steve G. Filton 2020 Irrevocable Trust.
Universal Health Services outlined 2026 incentive pay for senior executives and granted new stock-based awards. The compensation committee set target annual bonuses as a percentage of 2026 base salary, including 150% for CEO Marc D. Miller and 100% for other named executives, based on corporate and, for some leaders, divisional performance. Metrics include adjusted net income per diluted share and return on capital, with payouts ranging from 0% to 200% of target. The committee also approved a $1.07 million discretionary cash bonus for Executive Chairman Alan B. Miller for 2025.
For long-term incentives, the committee granted time-based restricted stock units and performance-based RSUs using a $185.09 share price. CEO Marc D. Miller received 29,715 RSUs and 29,715 PBRSUs, with similar but smaller awards for other executives. PBRSU payouts will now be based on three-year average Adjusted EBITDA net of noncontrolling interests, with 50% of target paid at 90% of the performance goal and up to 200% at 110% or more.